Related Experiment Videos

Cellular and signaling mechanisms of cardiac hypertrophy

M R Piano1

  • 1Department of Medical-Surgical Nursing, College of Nursing, University of Illinois at Chicago.

Insights

Left ventricular hypertrophy (LVH) is a risk factor for heart problems. Over time, this condition leads to heart failure through cellular damage and reduced blood supply.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Pathophysiology

Background:

  • Left ventricular hypertrophy (LVH) is a significant independent risk factor for cardiovascular morbidity and mortality.
  • Initially, LVH enhances myocardial contractility and pump function.
  • However, sustained LVH leads to detrimental changes including myofibril disintegration, fibrosis, and energy depletion.

Purpose of the Study:

  • To summarize the pathological progression of left ventricular hypertrophy.
  • To identify the key signaling pathways and molecular events involved in LVH development.
  • To highlight the transition from adaptive to maladaptive cardiac remodeling.

Main Methods:

  • Review of existing literature on the pathophysiology of LVH.
  • Analysis of molecular and cellular mechanisms underlying cardiac hypertrophy.
  • Identification of hemodynamic and nonhemodynamic stimuli triggering myocardial growth.

Main Results:

  • LVH progression involves myofibril breakdown, interstitial fibrosis, and ATP depletion.
  • Altered gene expression, including immediate early genes like c-fos and c-myc, plays a role.
  • Myocardial ischemia occurs as the heart muscle outgrows its vascular supply, leading to heart failure.

Conclusions:

  • LVH initiates as a compensatory mechanism but ultimately leads to heart failure.
  • Multiple signaling pathways, including hemodynamic and hormonal factors, contribute to LVH.
  • Understanding these mechanisms is crucial for developing therapeutic strategies against cardiovascular disease.

Related Concept Videos